Science in Action.
We are a 501(c)3 transforming how infection-associated chronic conditions like LongCovid, ME/CFS & LongLyme Disease are studied, diagnosed and treated.
Akiko Iwasaki PhD, Alessio Fasano MD, Amy Proal PhD, Christopher Dupont PhD, David Price MD PhD, David Putrino PhD, Diane Griffin PhD, Gene Tan PhD, John Wherry PhD, Lael Yonker MD, Marcelo Freire PhD DDS, Matthew Frank PhD, Michael Peluso MD, Michael VanElzakker PhD, Michela Locci PhD, Monika Fleshner PhD, Resia Pretorius PhD, Sara Cherry PhD, Saurabh Mehandru MD, Steven Deeks MD, Timothy Henrich MD
Infection-associated chronic conditions like LongCovid and ME/CFS are not mysterious or hopeless. The opposite is true: we can use new tools to study pathogen activity, environmental exposures, microbiome imbalances, neuroinflammation, gene changes, and other issues in patients with such conditions. PolyBio brings together some of the brightest minds in science to research these topics in a proactive and open-minded fashion.
The LongCovid Research Consortium is a scientific collaboration to rapidly and comprehensively study LongCovid. The program includes scientists and clinicians from institutions including Harvard Medical School, Stanford University, the J. Craig Venter Institute, University of Pennsylvania, the Icahn School of Medicine at Mount Sinai and Yale University.
Innovating neuroscience and NOT psychology. We study the brain itself, with a focus on neuroinflammation, blood vessel issues, cerebrospinal fluid flow, and potential structural problems.
Research on root cause drivers of chronic inflammatory disease. Getting to the “root cause” of illness leads to development of the most effective treatments.
Exploring new frontiers. We prioritize research that moves beyond just blood tests and towards the study of tissue, nerves, cerebrospinal fluid & autopsies.